The scale of dilution (existing shareholders will hold ~54% of the combined company) and the pre-revenue status of the Pela Ema mine (commercial ops not expected until 2027) suggest continued cash burn and potential for further equity issuances. Monitor the DOC milestone achievement timeline and the Q2 2026 fair value determination of the DOC warrant, which could be material.
Price Chart
Executive Summary
USA Rare Earth (USAR) filed updated pro forma financials and disclosures in connection with its pending acquisition of SVRE Holdings Ltd., the owner of the Pela Ema rare earth project in Brazil. The total consideration is $3.15 billion, comprising $300 million in cash and 126.8 million shares valued at $2.85 billion at USAR's June 5 closing price of $22.47. The combined entity would have $6.9 billion in total assets, including $3.2 billion in PP&E, $1.1 billion in goodwill, and $314 million in intangible assets (the offtake agreement). Pro forma operations show a net loss of $73.3 million for Q1 2026 and $453.1 million for FY 2025, with combined revenue of only $6.3 million and $4.1 million, respectively. The filing also details massive equity dilution: 126.8 million shares to SVRE holders (30.9% of fully-diluted), 16.1 million shares plus a 17.6 million-share warrant to the DOC, and 10.1 million earnout shares already issued. The DOC also committed up to $1.6 billion in funding ($277M direct, $1.3B loan guarantee), but draws are contingent on milestones not yet met. Significant transaction costs of $113 million are recognized.
Key Facts
- Total merger consideration for SVRE: $3.15 billion, comprising $300 million cash and 126.8 million USAR shares valued at $22.47/share.
- Pro forma combined total assets: $6.88 billion, including $3.2 billion PP&E (development-stage mine) and $1.1 billion goodwill.
- Pro forma revenue (Q1 2026): only $6.3 million; pro forma net loss: $73.3 million.
- Pro forma basic EPS (Q1 2026): -$0.21 on 349.6 million weighted average shares.
- Non-recurring transaction costs of $113 million recognized in FY 2025 pro forma P&L.
- Massive dilution: existing pre-merger shares represent only 54.3% of fully-diluted (410.8 million total shares).
- DOC CHIPS Act funding: up to $1.6 billion total ($277M grant + $1.3B loan guarantee), but draws contingent on milestones.
- DOC received 16.1 million common shares (value: ~$451 million) and a warrant for 17.6 million shares at $17.17.
- DFC committed $565 million in debt financing to SVRE; $325M drawn, $100M incremental closed June 4, 2026; DFC gets 12% equity interest via warrants.
- 10.1 million earnout shares were issued in April/May 2026 upon stock price thresholds being met ($15 and $20).
- Offtake agreement for 100% of Phase 1 Pela Ema production (up to 20 years) with floor pricing; deliveries not yet commenced.
- Commercial operations at Pela Ema expected to commence in 2027.
Financial Impact
Merger consideration $3.15 billion; pro forma net losses of $73M (Q1 2026) and $453M (FY 2025); non-recurring transaction costs $113M; DOC funding up to $1.6B contingent on milestones; DFC debt up to $565M with $325M drawn.
Risk Factors
- Massive dilution to existing shareholders: fully diluted share count of 410.8 million vs. 228.5 million currently outstanding.
- Pela Ema mine is a development-stage property; commercial operations not expected until 2027 — no near-term cash flow generation.
- DOC funding ($1.6B) is contingent on milestone achievement, project financing, and permits — none satisfied as of filing.
- Pro forma net losses of $73M (Q1 2026) and $453M (FY 2025) on negligible revenue signal ongoing cash burn.
- Goodwill of $1.13 billion (16% of total assets) creates impairment risk if Pela Ema development is delayed or fails.
- Deferred tax liability of $903 million — a large non-cash liability that could impact future earnings if reversal patterns shift.
- Offtake agreement deliveries not yet commenced; conditions precedent may not be satisfied by the long-stop date.
- DOC's 16.1M share issuance and 17.6M warrant at $17.17 present overhang risk.
- Cross-default risk: defaults under DOC funding could trigger defaults across other financing arrangements.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (USAR) — Batch item 1 | 0001213900-26-068491 |
| Document: ea0294574-8k_usarare.htm | 0001213900-26-068493 |
| Document: ea029457401ex99-2.htm | 0001213900-26-068491 |
| Document: 0001213900-26-068491-index-headers.html | 0001213900-26-068491 |
| Document: 0001213900-26-068491-index.html | 0001213900-26-068491 |
| Document: 0001213900-26-068491.txt | 0001213900-26-068491 |
| DEFA14A Filing (USAR) — Batch item 7 | 0001213900-26-068493 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $10.40 | awaiting T+5 | — | $10.40 (−0.00%) |
Oct 1, 2026 26d ago | 8-K | $13.80 $12.63 | ▼ −8.48% | ▼ −9.78% | $10.40 (−24.64%) |
Oct 1, 2026 26d ago | Press Release | $13.80 $12.63 | ▼ −8.48% | ▼ −9.78% | $10.40 (−24.64%) |
Sep 16, 2026 5w ago | EFFECT | $15.10 $16.78 | ▼ −11.13% | ▼ −8.29% | $10.40 (+31.13%) |
Sep 15, 2026 6w ago | 8-K | $15.10 $16.78 | ▼ −11.13% | ▼ −8.29% | $10.40 (+31.13%) |
Sep 4, 2026 7w ago | S-3 | $17.66 $15.40 | ▲ +12.80% | ▲ +11.68% | $10.40 (+41.11%) |
Sep 4, 2026 7w ago | S-3 | $17.66 $15.40 | ▲ +12.80% | ▲ +11.68% | $10.40 (+41.11%) |
Sep 4, 2026 7w ago | 8-K | $17.61 $15.71 | ▼ −10.79% | ▼ −9.58% | $10.40 (−40.94%) |
Aug 24, 2026 9w ago | DEFA14A | $18.29 $17.82 | ▼ −2.57% | ▼ −3.04% | $10.40 (−43.14%) |
Aug 24, 2026 9w ago | 8-K | $18.29 $17.82 | ▼ −2.57% | ▼ −3.04% | $10.40 (−43.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers